UNIVERSAL HEALTH SERVICES INC

NYSE: UHS·King of Prussia, Pennsylvania·

Price
$197.80
Base IV
$298.82

Valuation snapshot

Below base case

At $197.80, the price sits between our bear case ($120.08) and base case ($298.82).

Values per share, from an .

No growth
…
Loading earnings power
Base case
$298.82
above today's price · range $120.08–$485.09
Price vs base case
34% below
$197.80 against $298.82
Base casevalued by DCF
Price vs base
Priceclose 11‑16

Whisker on the base case runs bear $120.08 to bull $485.09. Values per share.

Price against each value

Bear case
$120.08
Price 65% above
No growth
…
—
Base case
$298.82
Price 34% below
Researched bygpt-6-sol
Valuation Nov 7, 2026 · Price as of Nov 16, 2026How we got here

What does Universal Health Services do?

Universal Health Services operates acute care hospitals and behavioral health facilities to provide medical, surgical, and psychiatric services to patients.

It brought in $18.4B of sales in the 12 months to Sep 2026.

Led by Marc D. Miller, President and Chief Executive Officer since 2021. Universal Health Services 2025 Form 10-K

Industry
Healthcare
Based in
King of Prussia, Pennsylvania
Trades on
NYSE as UHS

Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 8¢ was left as profit after every cost, interest and tax. The biggest cost is running the business, 89¢ of every dollar.

  • Running the business89¢
  • Tax3¢
  • Left as profit8¢
Totals of the four quarters to Sep 2026, from the company's own filings. The split by product is from the latest fiscal year.

Who pays Universal Health Services, and for what?

UHS owns and operates acute care hospitals, outpatient facilities and behavioral health facilities in the U.S., U.K. and Puerto Rico. It earns revenue mainly by providing patient care, with payments from private insurers, government programs and patients.

Its payers include private insurers and managed care plans, Medicare and Medicaid programs, other government health services, and patients.

  • Acute care, outpatient facilities and commercial health insurer

    57%

    Includes acute care hospitals and outpatient facilities, plus a commercial health insurer. The filing reports their revenue together.

  • Behavioral health facilities and commercial health insurer

    43%

    Includes behavioral health facilities, plus the commercial health insurer. The filing reports their revenue together.

Share of the latest fiscal year's sales, as the company reports it.

Where its work physically happens, beyond headquarters:

  • Western Region Consolidated Business Office — Las Vegas, United States. This regional office handles billing, collections and other revenue-cycle services for UHS acute care facilities in Nevada and California.
  • Nashville Regional Office — Brentwood, United States. UHS identifies this as a regional office; its 2025 Form 10-K also lists company-owned office property in Brentwood.
  • Western Region Office — Las Vegas, United States. UHS identifies this office as its Western Region location in Las Vegas, a market whose acute care facilities generated 15% of consolidated net revenue in 2025.
See them on the globe

2025 Form 10-K

How is the business doing?

Sales grew from $11.6B in 2020 to $17.4B in 2025, about 8% a year.

Running the business leaves about 11¢ of each sales dollar as operating profit, about the same as 12¢ in 2020.

After paying for its upkeep and new investment, it had $1.1B of cash to spare in the 12 months to Sep 2026.

Sales$17.4B
20162025
Operating margin11%
20162025
Free cash flow$849.2M
20162025
Each bar is one fiscal year (2016–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

UHS says it exists to provide high-quality healthcare that patients recommend, physicians prefer, purchasers select, employees are proud of and investors seek for long-term returns.

“To provide superior quality healthcare services”

Mission and Principles

Who is responsible for the plan?

Roles checked November 7, 2026.

What management says it is working on now:

  • Expand access to care

    Management says it is investing in hospital beds and convenient access points in communities where it sees demand, including outpatient services.

    Q2 2026 Earnings Call Transcript
  • Grow in high-demand markets

    Management says its strategy is to invest in high-growth markets and expand care access while serving patients and communities.

    Q2 2026 Earnings Call Transcript
  • Operate efficiently

    Management highlighted continued expense management and says it is working to moderate labor and other operating costs.

    Q2 2026 Earnings Call Transcript
  • Build outpatient behavioral health

    Management described Talkspace as a way to extend behavioral health care into virtual services and connect it with UHS’s existing inpatient and in-person outpatient services.

    Q2 2026 Earnings Call Transcript
2026 net revenue, 2026
$18.501 billion to $18.762 billion
Q2 2026 Financial Results and Revised Forecast
2026 adjusted EBITDA, net of noncontrolling interests, 2026
$2.610 billion to $2.717 billion
Q2 2026 Financial Results and Revised Forecast
2026 adjusted diluted earnings per share, 2026
$22.28 to $23.65
Q2 2026 Financial Results and Revised Forecast
Acute care adjusted admissions growth, Full year 2026
1.5% to 2.5%
Q2 2026 Earnings Call Transcript
Behavioral health adjusted patient day growth, Full year 2026
1.0% to 2.0%
Q2 2026 Earnings Call Transcript
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is slowing. In Q3 2026 it sold 5% more than a year earlier. The year before, quarters averaged 10%.

Its operating margin is narrower than a year ago: 10¢ per sales dollar, against 12¢.

Since Oct 2026 the share price has risen 12%, from $176.61 to $197.80.

Bull $485.09Base $298.82Bear $120.08Oct 30Nov 16 · $197.80
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start October 30, 2026.

Recently

  • November 6, 2026

    Nine-month Medicaid supplemental net benefit changed to $1.2B

    UHS Q3 2026 10-Q
  • November 6, 2026

    Acute care third-quarter same-facility revenue growth changed to 4.7%

    UHS Q3 2026 10-Q
  • November 6, 2026

    Third-quarter operating margin changed to 9.6%

    UHS Q3 2026 10-Q

Coming up

  • Expected October 28, 2026

    Quarterly results

    UHS is scheduled to report third-quarter 2026 results. The results may show how patient volumes, costs and reimbursement trends are developing.

    Q3 2026 Earnings Date Announcement
  • Anticipated in 2027

    Texas behavioral hospital recertification

    UHS expects to regain certification for a Texas behavioral health hospital, which would allow it to resume government and managed-care reimbursements. Management anticipates recertification in 2027.

    Q2 2026 Earnings Call Transcript
  • Beginning in 2028; increasing through 2032

    Medicaid payment reductions

    UHS estimates that changes to Medicaid funding will reduce its annual net benefit by about $432 million to $480 million by 2032, with reductions starting in 2028.

    2025 Form 10-K

Our own estimate moved too: the base case went from $328.16 to $298.82 a share between our last two valuations. The biggest reason: Acute care third-quarter same-facility revenue growth moved from an unreported prior value to 4.7%, as reported in UHS Q3 2026 10-Q.

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Government payment changes

    A large share of revenue comes from government health programs. UHS says new Medicaid rules and possible reductions in public funding could reduce payments, increase unpaid care and affect results.

    From the company's own filingsWould hit how fast sales grow2025 Form 10-K

  2. Concentration in three states

    Facilities in Texas, Nevada and California generated 44% of consolidated revenue in 2025. Changes in local payment rules, economies, weather or competition could therefore have an outsized effect.

    From the company's own filingsWould hit how fast sales grow2025 Form 10-K

  3. Staffing costs and availability

    Hospitals need enough nurses, physicians and other clinical staff to operate. Shortages can raise labor costs or force facilities to limit services and patient numbers.

    From the company's own filingsWould hit how much of each sale it keeps2025 Form 10-K

  4. Competition for patients and clinicians

    Hospitals and outpatient providers compete for patients, physicians and staff. UHS could lose volume if competitors offer broader services, attract more clinicians or secure better payer contracts.

    From the company's own filingsWould hit how fast sales grow2025 Form 10-K

  5. Healthcare laws and investigations

    UHS must follow complex rules on billing, patient privacy, referrals and government program participation. Investigations, penalties or loss of eligibility for public payments could harm its business and finances.

    From the company's own filingsWould hit how much of each sale it keeps2025 Form 10-K

  6. Cybersecurity incidents

    A cyberattack or data breach could disrupt hospital operations, expose sensitive patient information and lead to costs, penalties, lawsuits or reputational harm.

    From the company's own filingsWould hit how much of each sale it keeps2025 Form 10-K

  7. Q3 same-facility revenue growth slowed to 0.047 in acute care and 0.04 in behavioral health.

    From our researchWould hit how fast sales growUHS Q3 2026 results

  8. Q3 2026 operating income declined while salaries and other operating expenses rose.

    From our researchWould hit how much of each sale it keepsUHS Q3 2026 10-Q

Is it a good business?

From 2016 to 2025 it earned between 7% and 13% on the capital invested in it, a median of 11%. Its cost of capital in the latest valuation is 7.7%; returns were above it in 9 of the 10 years.

From 2016 to 2025 it earned between 11% and 20% on its shareholders' equity, a median of 15%.

Over 10 years its operating margin ranged from 7¢ to 13¢ per sales dollar, a median of 11¢.

derived computed from the filingsassumption cost of capital from the latest valuation
Return on invested capital13%
20162025

Cost of capital 7.7%

Return on equity20%
20162025
Return on invested capital is operating profit after tax (at the median effective rate, 24%) over debt plus equity less cash at each fiscal year end. Return on equity is net income over equity. Both are computed from published quarters.

It bought back shares: the count fell 7.1% in a year, so each remaining share owns a slightly bigger slice.

It owes $5.5B more than it holds in cash, about 2.8 years of operating profit.

What might it be worth?

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $197.80. Our put its value between $120.08 and $485.09, with $298.82 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, $120.08

Although UHS kept growing this year, this case assumes payments weaken, new hospitals remain costly, and growth slows markedly.

Base case, $298.82

UHS continues to grow after this year's slowdown, while its newer hospitals improve enough to restore some of the profit lost in the latest quarter.

Bull case, $485.09

Despite slower growth and lower profits in the latest quarter, this case assumes more patients, expanded services, and better use of hospitals restore stronger growth and earnings.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price expects less than we do.Margin of safety: 34%

At today's $197.80, the price makes sense if sales shrink about 1.8% a year. We assume they grow 4.8%. Over the last 5 years, sales grew 8.1% a year.

−5%−2.5%0%+2.5%+5%+7.5%+10%Price needs −1.8%We assume 4.8%Past 5 yrs 8.1%

Or, if sales grow 4.8% as we assume, the price works with a profit margin of 8.2% (we assume 11.0%).

Keep in mind: a low price can mean investors see a risk that isn't in the filings yet. Check the Full research tab for what could go wrong.

Do you think sales will shrink?

Try your own numbers

We're moderately sure of this range: it scores 58 out of 100 on our checks. The weakest point is terminal-value dependency.

Test the assumptions

Our base value of $298.82 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average4.8%
  • Operating margin11.0%
  • Long-term growth rate2.2%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$298.82 51.1%

Build